Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus (HBV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02174276
What this trial is testing

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 195
Large-scale testing (Phase 3)Study completedNCT05630820
What this trial is testing

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

Who this might be right for
Chronic Hepatitis BHepatitis B, Chronic
GlaxoSmithKline 857
Large-scale testing (Phase 3)Study completedNCT00291980
What this trial is testing

Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Who this might be right for
Hepatitis B
Henogen 185
Large-scale testing (Phase 3)Ended earlyNCT00120796
What this trial is testing

Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)

Who this might be right for
Hepatitis B
French National Agency for Research on AIDS and Viral Hepatitis 8
Post-approval studies (Phase 4)Study completedNCT05705427
What this trial is testing

The COMBAT HBV Feasibility Trial

Who this might be right for
Hepatitis BVertical Transmission of Infectious Disease
University of North Carolina, Chapel Hill 317
Not applicableStudy completedNCT01452503
What this trial is testing

Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6

Who this might be right for
Contraception
FHI 360 170
Not applicableNot Yet RecruitingNCT06596213
What this trial is testing

Hepatitis Inequalities Study

Who this might be right for
Chronic Hepatitis BHEPATITIS C VIRUS CHRONIC INFECTION
Chinese University of Hong Kong 100,000
Not applicableWithdrawnNCT03373123
What this trial is testing

Radiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703)

Who this might be right for
Esophageal Varices in Cirrhosis of the Liver
Nanfang Hospital, Southern Medical University
Not applicableStudy completedNCT00946010
What this trial is testing

Investigation of Hepatitis B and Hepatitis C in Taiwan

Who this might be right for
Hepatitis BHepatitis C
National Taiwan University Hospital 6,228
Post-approval studies (Phase 4)Study completedNCT03471624
What this trial is testing

Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)

Who this might be right for
Hepatitis B, Chronic
Stanford University 270
Post-approval studies (Phase 4)Study completedNCT01627340
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Who this might be right for
Hepatitis B
GlaxoSmithKline 667
Not applicableStudy completedNCT01163240
What this trial is testing

Epidemiological Study in Children and Adolescents With Chronic Hepatitis B

Who this might be right for
Liver DiseasesHepatitis, ChronicHepatitis, Viral, Human+6 more
Novartis Pharmaceuticals 1,640
Testing effectiveness (Phase 2)Study completedNCT04585789
What this trial is testing

Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Janssen Research & Development, LLC 24
Post-approval studies (Phase 4)UnknownNCT02362490
What this trial is testing

Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 200
Testing effectiveness (Phase 2)Study completedNCT05244057
What this trial is testing

Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Shanghai HEP Pharmaceutical Co., Ltd. 8
Post-approval studies (Phase 4)Study completedNCT05355467
What this trial is testing

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum

Who this might be right for
Chronic Hepatitis B Infection
Mylan (Taiwan) Ltd 40
Not applicableUnknownNCT01243281
What this trial is testing

Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chulalongkorn University 126
Not applicableStudy completedNCT01412567
What this trial is testing

Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers

Who this might be right for
Chronic Hepatitis B
Govind Ballabh Pant Hospital 259
Not applicableStudy completedNCT07154212
What this trial is testing

Hepatitis B Virus Reactivation in COVID-19

Who this might be right for
COVID-19 PneumoniaHypoxemiaHepatitis B
University Medical Centre Ljubljana 1,793
Early research (Phase 1)Looking for participantsNCT06680232
What this trial is testing

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

Who this might be right for
HEPATITIS B CHRONIC
Precision BioSciences, Inc. 45
Next Page